EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104
by Böck, Stefan (Author)
, Jung, A. (Author)
, Laubender, R. P. (Author)
, Neumann, J. (Author)
, Egg, R. (Author)
, Goritschan, C. (Author)
, Vehling-Kaiser, U. (Author)
, Winkelmann, C. (Author)
, Fischer von Weikersthal, L. (Author)
, Clemens, M. R. (Author)
, Gauler, T. C. (Author)
, Märten, Angela (Author)
, Klein, S. (Author)
, Kojouharoff, G. (Author)
, Barner, M. (Author)
, Geissler, M. (Author)
, Greten, T. F. (Author)
, Mansmann, U. (Author)
, Kirchner, T. (Author)
, Heinemann, V. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource